PHASE-I TRIAL OF RECOMBINANT TUMOR-NECROSIS-FACTOR (RTNF) IN PATIENTS WITH ADVANCED MALIGNANCY

被引：0
|
作者：
KRIGEL, R
COMIS, R
PADAVIC, K
RUDOLPH, A
机构：
[1] FOX CHASE CANC CTR,PHILADELPHIA,PA 19111
[2] CETUS CORP,EMERYVILLE,CA 94608
来源：
CLINICAL RESEARCH | 1987年 / 35卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：A806 / A806
页数：1
相关论文
共 50 条
  • [1] A PHASE-I TRIAL OF SUBCUTANEOUSLY ADMINISTERED RECOMBINANT TUMOR NECROSIS FACTOR TO PATIENTS WITH ADVANCED MALIGNANCY
    ZAMKOFF, KW
    NEWMAN, NB
    RUDOLPH, AR
    YOUNG, J
    POIESZ, BJ
    [J]. JOURNAL OF BIOLOGICAL RESPONSE MODIFIERS, 1989, 8 (05): : 539 - 552
  • [2] METABOLIC CHANGES IN PATIENTS TREATED IN A PHASE-I TRIAL OF RECOMBINANT TUMOR NECROSIS FACTOR (RTNF)
    KRIGEL, R
    PADAVIC, K
    OTTERY, F
    RUDOLPH, A
    COMIS, R
    [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1988, 29 : 432 - 432
  • [3] PHASE-I TRIAL OF RECOMBINANT TUMOR-NECROSIS-FACTOR-ALPHA IN ADVANCED MALIGNANCY
    GAMM, H
    MEYENBURG, W
    HERRMANN, F
    MERTELSMANN, R
    [J]. BLUT, 1986, 53 (03): : 231 - 232
  • [4] PHASE-I TRIAL OF RECOMBINANT HUMAN TUMOR-NECROSIS-FACTOR-ALPHA IN PATIENTS WITH ADVANCED MALIGNANCY
    GAMM, H
    LINDEMANN, A
    MERTELSMANN, R
    HERRMANN, F
    [J]. EUROPEAN JOURNAL OF CANCER, 1991, 27 (07) : 856 - 863
  • [5] PHASE-I TRIAL OF RECOMBINANT TUMOR-NECROSIS-FACTOR-ALPHA (TNF) IN ADVANCED MALIGNANCY
    GAMM, H
    MEYENBURG, W
    HERRMANN, F
    MERTELSMANN, R
    [J]. IMMUNOBIOLOGY, 1987, 175 (1-2) : 22 - 22
  • [6] PHASE-I TRIAL OF RECOMBINANT TUMOR-NECROSIS-FACTOR-ALPHA (TNF) IN ADVANCED MALIGNANCY
    GAMM, H
    MEYENBURG, W
    HERRMANN, F
    MERTELSMANN, R
    [J]. INVESTIGATIONAL NEW DRUGS, 1987, 5 (01) : 99 - 99
  • [7] GRANULOCYTOPENIA IN CANCER-PATIENTS TREATED IN A PHASE-I TRIAL WITH RECOMBINANT TUMOR-NECROSIS-FACTOR
    LOGAN, TF
    KAPLAN, SS
    BRYANT, JL
    ERNSTOFF, MS
    KRAUSE, JR
    KIRKWOOD, JM
    [J]. CLINICAL RESEARCH, 1990, 38 (02): : A549 - A549
  • [8] PHASE-I STUDY OF THE SEQUENTIAL ADMINISTRATION OF RECOMBINANT TUMOR NECROSIS FACTOR (RTNF) AND RECOMBINANT INTERLEUKIN-2 (RIL-2) IN PATIENTS WITH ADVANCED MALIGNANCY
    SCHWARTZBERG, L
    TAUER, K
    WEST, W
    [J]. JOURNAL OF BIOLOGICAL RESPONSE MODIFIERS, 1989, 8 (03): : 314 - 314
  • [9] PHASE-I STUDY OF RECOMBINANT TUMOR-NECROSIS-FACTOR IN CANCER-PATIENTS
    BLICK, M
    SHERWIN, SA
    ROSENBLUM, M
    GUTTERMAN, J
    [J]. CANCER RESEARCH, 1987, 47 (11) : 2986 - 2989
  • [10] GRANULOCYTOPENIA IN CANCER-PATIENTS TREATED IN A PHASE-I TRIAL WITH RECOMBINANT HUMAN TUMOR-NECROSIS-FACTOR
    LOGAN, TF
    KAPLAN, SS
    BRYANT, JL
    ERNSTOFF, MS
    KRAUSE, JR
    KIRKWOOD, JM
    [J]. JOURNAL OF IMMUNOTHERAPY, 1991, 10 (02): : 84 - 95
12345